共 104 条
[1]
Tosh JC(2011)Utility values in National Institute for Health and Clinical Excellence (NICE) Technology Appraisals Value Health 14 102-109
[2]
Longworth LJ(2012)Developing and testing methods for deriving preference-based measures of health from condition-specific measures (and other patient-based measures of outcome) Health Technol Assess 16 1-114
[3]
George E(2009)Mapping the EORTC QLQ-C-30 onto the EQ-5D instrument: the potential to estimate QALYs without generic preference data Value Health 12 167-171
[4]
Brazier JE(1989)Generic and disease-specific measures in assessing health status and quality of life Med Care 27 S217-S232
[5]
Rowen D(2012)Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial Eur J Haematol 89 16-27
[6]
Mavranezouli I(2013)Lenalidomide, melphalan and prednisone followed by lenalidomide maintenance improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial Haematologica 98 784-788
[7]
Tsuchiya A(2011)The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities Health Qual Life Outcomes 9 106-1203
[8]
Young T(2012)Mapping the cancer-specific EORTC QLQ-C30 and EORTC QLQ-BR23 to the generic EQ-5D in metastatic breast cancer patients Qual Life Res 21 1193-1157
[9]
Yang Y(2009)Mapping the cancer-specific EORTC QLQ-C30 to the preference-based EQ-5D, SF-6D, and 15D instruments Value Health 12 1151-434
[10]
Barkham M(2010)Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences Eur J Health Econ 11 427-414